Senators Fight For Cannabis Industry Access To Federal Small Business Administration Financing
A group of Democratic Senators is urging the Senate Appropriations Subcommittee to level the playing field for the state-legal marijuana industry by adding to the Fiscal Year 2025 Financial Services and General Government Related Agencies (FSGG) spending provisions to prevent Small Business Administration (SBA) "from denying loan applications for the 7(a) Loan Guarantee Program, Disaster Assistance Program, Microloan Program, and 504/Certified Development Company Loan Program to legally operating cannabis small businesses in states that have legalized cannabis sale and use."
The ten-member coalition led by Sen. Jacky Rosen (D-NV) highlighted that "SBA's current policy excludes from its loan and entrepreneurial development programs all small businesses with ‘direct' or ‘indirect' products or services that aid the use, growth, enhancement, or other development of cannabis," the senators wrote in the letter, reported Marijuana Moment.
Nearly Half Of All Gun Permits In Hawaii Rejected Due To Cannabis
Nearly half (40.7%) of 519 firearm permit applications that didn't get a green light from Hawaii officials last year faced rejection due to applicants' status as medical marijuana patients, reported Marijuana Moment citing the latest data from the state attorney general's office.
A quarter of applicants who were denied a gun permit can blame mental health issues for the outcome, while 7% of applicants were rejected due to domestic violence. A total of 23,528 applications were part of the process in 2023.
Now read: Medical Cannabis & Gun Rights: Will I Lose My Guns If I Obtain A Patient Card?
Public Comments Favor Cannabis Rescheduling
It seems that cannabis rescheduling is just around the corner with public support for the policy change growing by day.
The Drug Enforcement Administration has been accepting public comments on the issue for two weeks. So far, the federal agency received 11,000 submissions, reported the Green Market Report.
According to an analysis by Headset, 97% of the comments submitted in the first week favored the policy change.
DEA will review all information following the closure of the public comment period, which is due July 22.
Cannabis rescheduling seems to be right around the corner. Want to understand what this means for the future of the industry?
Join the Benzinga Cannabis Market Spotlight in New Jersey on June 17th! Grow your business, raise money and capitalize on the booming NJ recreational market. Don't miss this must-attend event in New Brunswick. Secure your tickets now. Very few spots are left. Use the code “JAVIER20” for 20% off!
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.